BIOCLINICA INC Clinical Trials
Studies registered on ClinicalTrials.gov (U.S. National Library of Medicine) with the company as lead sponsor or collaborator, newest start first. Values are as registered.
- 2021-04-24: Study NCT04796350; Company role Collaborator; Phase Not applicable; Status Recruiting.
- 2021-02-08: Study NCT04607005; Company role Collaborator; Phase Phase 3; Status Completed.
- 2019-10-25: Study NCT05713773; Company role Collaborator; Phase Phase 1; Status Completed.
- 2019-06-25: Study NCT03981822; Company role Collaborator; Phase Phase 2; Status Completed.
| Start date | Study | Company role | Phase | Status | Conditions | Enrollment | Completion date |
|---|---|---|---|---|---|---|---|
| 2021-04-24 | NCT04796350 RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures | Collaborator Lead: AgNovos Healthcare, LLC | Not applicable | Recruiting | Fragility Fracture; Hip Fractures; Osteoporosis | 2,400 | 2029-04-01 |
| 2021-02-08 | NCT04607005 Efficacy and Safety of Mepolizumab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)/ Eosinophilic Chronic Rhinosinusitis (ECRS) | Collaborator Lead: GlaxoSmithKline | Phase 3 | Completed Results posted | Nasal Polyps | 169 | 2023-07-04 |
| 2019-10-25 | NCT05713773 Pharmacodynamics and Pharmacokinetics of 3 New Developed Coated Glucose Beads in 20 Obese Healthy Subjects | Collaborator Lead: Aphaia Pharma US LLC | Phase 1 | Completed | Metabolic Syndrome; Obesity | 20 | 2019-12-03 |
| 2019-06-25 | NCT03981822 A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts | Collaborator Lead: Verrica Pharmaceuticals Inc. | Phase 2 | Completed Results posted | Condylomata Acuminata; Papillomavirus Infections; Skin Diseases, Viral; Skin Diseases, Infectious; Skin Diseases; Sexually Transmitted Diseases, Viral; Sexually Transmitted Diseases; Warts | 105 | 2020-07-08 |
| 2018-03-27 | NCT03487549 Cantharidin and Occlusion in Verruca Epithelium | Collaborator Lead: Verrica Pharmaceuticals Inc. | Phase 2 | Completed Results posted | Common Wart; Warts Hand; Warts; Papillomavirus Infections; DNA Virus Infections; Skin Diseases, Viral; Skin Diseases, Infectious; Skin Diseases; Virus Diseases; Tumor Virus Infections; Verruca Vulgaris; Verruca | 56 | 2019-07-15 |
| 2017-01-17 | NCT03333447 Retrospective and Prospective Observational Study of MRI Changes in Bone and Visceral Lesions of Patients With Type 1 Gaucher Disease Treated With VPRIV® (Velaglucerase Alfa) | Collaborator Lead: CEN Biotech | Observational | Completed | Gaucher Disease, Type 1; MRI | 20 | 2018-12-27 |
| 2014-04 | NCT02119091 Race Difference Moxifloxacin-induced QT Prolongation Between Healthy Chinese and Caucasian Volunteers | Collaborator Lead: Haiyan Li | Phase 1 | Unknown | Cardiac Toxicity | 80 | 2014-12 |
| 2008-09 | NCT01692353 Cardiovascular Disease Biomarkers in Smokers and Moist Snuff Consumers | Collaborator Lead: R.J. Reynolds Tobacco Company | Observational | Completed | Cardiovascular Disease; Cigarette Smoking | 168 | 2009-04 |